A Study on Postcovid-19 Patients Assessing the correlation between Covid-19 Infection and an Increased Risk of New-onset Diabetes (NOD)
الباحث الأول:
Alquraishi, Mohammed. K. S
الباحثين الآخرين:
Al-Hakeem, Mohammed A.M
Alfatlawi, Mustafa H
Rashid, Ammar A
Al-Bayati, Maha M.
المجلة:
Egyptian Journal of Medical Microbiology
تاريخ النشر:
1 إبريل، 2025
مختصر البحث:
Background: The SARS-CoV-2 pandemic is characterized by multiple cases and high
rates of morbidity and mortality in individuals with predisposing risk factors. 1- to 50
people who have been infected with SARS-CoV-2 are thought to have developed po…
Background: The SARS-CoV-2 pandemic is characterized by multiple cases and high
rates of morbidity and mortality in individuals with predisposing risk factors. 1- to 50
people who have been infected with SARS-CoV-2 are thought to have developed post-
COVID-19 symptoms. Several studies have recently indicated new-onset diabetes
associated with COVID-19. Preliminary observations suggest that new-onset
diabetes (NOD) after COVID-19 infection is a miracle. Objectives: This study focuses
on the chain of events that follow infection with COVID-19. It investigates the effects
of infection-related onset diabetes known as newly diagnosed diabetes (NDD).
Methodology: This Study included 100 cases of females and males. It was confirmed
that all patients were actually infected with Covid-19, which were part of the current
prospective experimental study they were divided in three groups, after testing
positively by a rapid antigen test or rapid antibody test. During the three-months
follow-up, the cases that developed NOPD and NODM as well as the threat factors
related to them were evaluated. Results: The first group whose HbA1c levels were
examined actually developed diabetes (NOD) as a result of their infection with
COVID-19 disease, the second group were in the early stage of diabetes (NOPD);
Cases diagnosed with NODM had an HbA1c > 6.4. The HbA1c range of 5.7 to 6.4
was utilized to describe NOPD, whereas the third group that was infected with
Covid-19 and after that did not develop any form of diabetes. Conclusion: A
considerable proportion of initial non-diabetic cases experienced new-onset
hyperglycemia following COVID-19 infection.
